Suppression of either LPIN1 by genetic knockdown or ChoKɑ1 by small molecule inhibitors suppressed leukemic expansion and might thus offer novel therapeutic approaches in AML (Figure 6F). Here, LPIN1 is linked to acute myeloid leukemia.